Citius Oncology, Inc. (CTOR) stock
CTORNasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.52−0.03 (-5.87%)
Close on Nov 12, 2026Market cap $48.56MP/E –Yield –
Citius Oncology cash
Cash and short-term investments held at the end of each period.
Citius Oncology's cash was $16.56M at Jun 30, 2026. For fiscal 2025 it was $3.92M, up 1257.3% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $3.92M | +1257.3% |
| FY2022 | Dec 31, 2022 | $289.18K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $16.56M | +14788922.3% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $2.63M | +2350466.1% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $7.30M | +6513695.5% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $3.92M | +1257.3% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $112 | – |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $112 | – |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $112 | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $289.18K | – |
See a number that looks wrong?